Two-thirds of people with HIV/HCV co-infection in Southeast Asia in need of HCV therapy
Study finds higher than expected hepatitis C prevalence among HIV-negative gay men in Amsterdam PrEP programme
Harm reduction should address the specific needs of couples who inject drugs
Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals
DAA therapy cures most people with HIV/HCV co-infection with decompensated cirrhosis or liver transplants
Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?
New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands
